Fecal Microbiota Transplant for Clostridium difficile Infection in a Pregnant Patient.
Clostridium difficile infection has been associated with negative outcomes in the general population and in pregnant patients. Fecal microbiota transplant has become the standard for treatment of recurrent as well as refractory C difficile infection.



We present a case of a 28-year-old pregnant woman who presented with recurrent C difficile infection despite treatment with vancomycin and fidaxomicin and underwent a successful fecal microbiota transplant through colonoscopy at 18 weeks of gestation. She no longer required antibiotics for the remainder of her pregnancy to treat C difficile and had a term vaginal delivery at 39 weeks of gestation.



Our pregnant patient tolerated and responded to a fecal microbiota transplant for treatment of recurrent C difficile infection. Future large-scale studies are needed to determine the efficacy, safety, and long-term effects of manipulating the microbiome in pregnant patients and the neonates.
School of Medicine, the Departments of Medicine and Pathology and Laboratory Medicine, and the Division of Digestive Diseases, Emory University, Atlanta, Georgia.
Bejan J
BJ
Saeedi
Doree Gardner
DG
Morison
Colleen S
CS
Kraft
Tanvi
T
Dhere
D000328:Adult; D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000628:therapy*; D000069467:Fecal Microbiota Transplantation; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy*; D012008:Recurrence